Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

Australian regulator warns of ‘rare but severe’ eye disorder linked to GLP-1 drugs like Ozempic

TGA says product information for some diabetes and weight loss drugs updated with warning of NAION disorder

The Guardian - AU

Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year

After 80 weeks of treatment, obese, non-diabetic participants receiving retatrutide lost an average of 22.6% of their body weight while also showing improvements in several cardiometabolic risk factors.

International Business Times

Weight loss drugs linked to loss of hair in major new study

The study looked at 50,000 people on GLP-1 agonist drugs such as Wegovy and Mounjaro

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Dietitians and Sleep Doctors Say TikTok's "Early Bird Dinner" Trend Is Actually Backed by Science

TikTok's early bird dinner trend has real science behind it. Sleep specialists and dietitians explain what eating earlier does to your body and who should be cautious.

Medical Daily

Target ultra-processed food to reduce obesity in Britain

Letter: James Capon responds to an editorial on the health select committee’s call for radical action to regulate food markets

The Guardian - UK

GLP-1 Drugs Like Ozempic Carry Elevated Risks of Muscle Loss and Malnutrition in Adults Over 65

GLP-1 drugs carry higher muscle loss, malnutrition, and bone density risks in adults over 65 that younger users don't face. Here's what older patients and prescribers need to know.

Medical Daily

A change in tradition

According to the Thai Health Promotion Foundation (Thai Health), monks are at 78% risk of developing non-communicable diseases, with the key factor being that food offered to them during alms-giving is often excessively sweet, fatty or salty.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

A Record 40 Million Americans Are Now Taking GLP-1 Weight-Loss Drugs as Medicare Coverage Begins

A Gallup survey shows 11% of Americans now take GLP-1 drugs for weight loss as Medicare begins covering them for $50 monthly. Here's what it means for you.

Medical Daily

The Guardian view on obesity: put public health before food industry pressure

Editorial: Obesity reflects prices, advertising and access, not simply weak willpower. Ministers must now act

The Guardian - UK

Government must ‘stand up to the food industry’ to tackle obesity epidemic – MPs

All outdoor advertising of junk food should be banned and front-of-pack labelling should be mandatory, the Health and Social Care Committee said.

Evening Standard

Being out-of-shape raises risk of type 2 diabetes by more than 3 times, researchers warn

15 percent of people with both excess body fat and poor muscle health developed type 2 diabetes within a decade, study finds

The Independent UK

Wimbledon finalist Alexander Zverev is using his tennis success to raise diabetes awareness

Alexander Zverev has more than just defending champion Jannik Sinner to deal with on Sunday in the Wimbledon final

The Independent UK

Men’s testosterone levels have fallen by half in last 50 years, scientists warn

Environmental factors like hormone-disrupting substances may be contributing to testosterone decline, scientists say

The Independent UK

Exhaustion, Brain Fog, and Low Mood Aren't Always Burnout—Here's The Diagnosis Women Are Missing

1 in 8 women in the UK is living with the condition.

Marie Claire

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

Ozempic and Wegovy Dosing Errors Drove Poison Control Calls from 1,500 to 8,000 a Year

Semaglutide dosing errors drove poison control calls from 1,500 to 8,000 annually after Wegovy's 2021 approval. Here's exactly what not to do with Ozempic and Wegovy.

The Independent UK

Study finds most weight loss drugs including Wegovy and Mounjaro ‘do not improve quality of life’

Wegovy pills found to have less positive impact on heart health than injectable counterparts

Marie Claire

Move Aside, Fibremaxxing—I Tested This Viral Fibre Supplement For A Month and The Results Blew Me Away

Forget protein for a second, *almost* all of us need more fibre.

The Independent UK

Domino’s, Papa John’s, KFC and Burger King ads cleared under new junk food rules

The ASA acknowledged that ‘specific products that people understandably assume are less healthy, are not in fact classified as less healthy’.

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Men’s average testosterone levels have halved in last 50 years, say scientists

Exclusive: Researchers warn of ‘major crisis in male reproductive health’ partly driven by obesity and diabetes

The Independent UK

The surprising effect sleep deprivation can have on the body in just six weeks

Sleep deprivation has been linked to changes in appetite and weight gain, but researchers say this could happen in just six weeks

Newsroom.co.nz

Clinging to hope when your world is kicked out from under you

Comment: What began as a grandmother's fight to help her daughter get back custody of her twins has become a case of medical negligence and broken systems. She tells Newsroom her story.

The Guardian - US

Pilot program to provide cheaper GLP-1 via Medicare stokes shortage fears

Some adults aged 65 and above will be able to get the drug for $50 through Medicare GLP-1, a temporary program

Newcastle Herald

'Big shock': after her diagnosis, Karen lost 30 kilograms in three years

'I had no inkling that anything was wrong.'

The Independent UK

Arkansas defies court ruling with new SNAP ban on candy and soda starting this week

Arkansas is moving forward with a ban on allowing government food aid to be used for candy and soda

International Business Times UK

Did Trump Get Experimental Obesity Drug? Rep Lieu Demands Answers Over FDA's 'Powerful Drug' Given to 'Unidentified 79-Year-Old Man'

Representative Ted Lieu questions the White House about claims that President Trump accessed an experimental obesity drug reserved for the gravely ill, sparking controversy and speculation.

1 2 3 4 5

People

Sarah Huckabee Sanders

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Nature Communications

98 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.